Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells
- PMID: 26407947
- DOI: 10.1016/j.phymed.2015.08.002
Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells
Abstract
Background: Apoptosis and other forms of cell death have been intensively investigated in the past years to explain the mode of action of synthetic anticancer drugs and natural products. Recently, a new form of cell death emerged, which was termed ferroptosis, because it depends on intracellular iron. Here, the role of genes involved in iron metabolism and homeostasis for the cytotoxicity of ten artemisinin derivatives have been systematically investigated.
Material and methods: Log10IC50 values of 10 artemisinin derivatives (artesunate, artemether, arteether, artenimol, artemisitene, arteanuin B, another monomeric artemisinin derivative and three artemisinin dimer molecules) were correlated to the microarray-based mRNA expression of 30 iron-related genes in 60 cell lines of the National Cancer Institute (NCI, USA) as determined in 218 different microarray hybridization experiments. The effect of desferoxamine and ferrostatin-1 on the cytotoxicity of artenimol of CCRF-CEM cells was determined by resazurin assays. The mRNA expression of TFRC was exemplarily validated by immunohistochemical detection of transferrin receptor protein expression.
Results: The mRNA expression of 20 genes represented by 59 different cDNA clones significantly correlated to the log10IC50 values for the artemisinins, including genes encoding transferrin (TF), transferrin receptors 1 and 2 (TFRC, TFR2), cerulopasmin (CP), lactoferrin (LTF) and others. The ferroptosis inhibitor ferrostatin-1 and the iron chelator deferoxamine led to a significantly reduced cytotoxicity of artenimol, indicating ferroptosis as cell death mode.
Conclusion: The numerous iron-related genes, whose expression correlated with the response to artemisinin derivatives speak in factor for the relevance of iron for the cytotoxic activity of these compounds. Treatment with ferroptosis-inducing agents such as artemisinin derivatives represents an attractive strategy for cancer therapy. Pre-therapeutic determination of iron-related genes may indicate tumor sensitivity to artemisinins. Ferroptosis induced by artemisinin-type drugs deserve further investigation for individualized tumor therapy.
Keywords: Cancer; Cell death; Iron; Microarray; Pharmacogenomics.
Copyright © 2015 Elsevier GmbH. All rights reserved.
Similar articles
-
Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib.Int J Cancer. 2013 Oct 1;133(7):1732-42. doi: 10.1002/ijc.28159. Epub 2013 Apr 8. Int J Cancer. 2013. PMID: 23505071
-
Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron.Free Radic Biol Med. 2004 Oct 1;37(7):998-1009. doi: 10.1016/j.freeradbiomed.2004.06.023. Free Radic Biol Med. 2004. PMID: 15336316
-
Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells.Cell Death Dis. 2016 Jul 21;7(7):e2307. doi: 10.1038/cddis.2016.208. Cell Death Dis. 2016. PMID: 27441659 Free PMC article.
-
Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation.Int J Pharm. 2008 Apr 16;354(1-2):28-33. doi: 10.1016/j.ijpharm.2007.09.003. Epub 2007 Sep 6. Int J Pharm. 2008. PMID: 17942255 Review.
-
Ferroptosis: A New Research Direction of Artemisinin and Its Derivatives in Anti-Cancer Treatment.Am J Chin Med. 2024;52(1):161-181. doi: 10.1142/S0192415X24500071. Epub 2024 Feb 7. Am J Chin Med. 2024. PMID: 38328829 Review.
Cited by
-
Redox-Regulated Iron Metabolism and Ferroptosis in Ovarian Cancer: Molecular Insights and Therapeutic Opportunities.Antioxidants (Basel). 2024 Jun 28;13(7):791. doi: 10.3390/antiox13070791. Antioxidants (Basel). 2024. PMID: 39061859 Free PMC article. Review.
-
Natural products targeting ferroptosis pathways in cancer therapy (Review).Oncol Rep. 2024 Sep;52(3):123. doi: 10.3892/or.2024.8782. Epub 2024 Jul 26. Oncol Rep. 2024. PMID: 39054952 Free PMC article. Review.
-
A targetable PRR11-DHODH axis drives ferroptosis- and temozolomide-resistance in glioblastoma.Redox Biol. 2024 Jul;73:103220. doi: 10.1016/j.redox.2024.103220. Epub 2024 May 30. Redox Biol. 2024. PMID: 38838551 Free PMC article.
-
Potential therapies for HCC involving targeting the ferroptosis pathway.Am J Cancer Res. 2024 Apr 15;14(4):1446-1465. doi: 10.62347/SIGP9279. eCollection 2024. Am J Cancer Res. 2024. PMID: 38726269 Free PMC article. Review.
-
Ferroptosis mechanisms and regulations in cardiovascular diseases in the past, present, and future.Cell Biol Toxicol. 2024 Mar 21;40(1):17. doi: 10.1007/s10565-024-09853-w. Cell Biol Toxicol. 2024. PMID: 38509409 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous